Caredx Inc sell nvestor
Start price
04.03.23
/
50%
€8.50
Target price
04.03.24
€4.00
Performance (%)
-13.49%
End price
16.09.23
€7.35
Summary
This prediction ended on 16.09.23 with a price of €7.35. The price of Caredx Inc decreased from the start of the prediction. Compared to the start price this resulted in a performance of -13.49%. nvestor has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Caredx Inc | 1.980% | 1.980% | 307.517% | 362.921% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % | 65,58 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % | 90,18 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % | 84,99 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % | 70,76 % |